BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  InMed Announces Changes to its Board of Directors

  InMed Pharmaceuticals Inc. is pleased to announce the appointment of Nicole Lemerond to its Board of Directors, effective immediately.

  August 9, 2022

   · 

  4 min read
• Business

  Xilio Therapeutics Announces Encouraging Preliminary Phase 1 Dose-Escalation Data for XTX101, a Tumor-Selective Anti-CTLA-4, and Reports Pipeline and Business Updates and Second Quarter 2022 Financial Results

  Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-selective immuno-oncology therapies for people living with cancer, today announced pipeline and business updates and reported financial results for the second quarter ended June 30, 2022.

  August 9, 2022

   · 

  16 min read
• Pharm Country

  Trevi Therapeutics to Present at Upcoming August Conferences

  Trevi Therapeutics, Inc. today announced it will be presenting at the following investor and medical meeting conferences.

  August 9, 2022

   · 

  2 min read
• Genetown

  BIONIK Laboratories Corp. to Present at Investor Summit Group’s Q3 Virtual Conference

  BIONIK Laboratories Corp. today announced that Rich Russo, Chief Financial Officer and Interim Chief Executive Officer, will be presenting a corporate overview and meeting with institutional investors at the Q3 Virtual Investor Summit.

  August 9, 2022

   · 

  1 min read
• Business

  908 Devices Reports Second Quarter 2022 Financial Results and Reiterates 2022 Revenue Outlook

  908 Devices Inc. today reported financial results for the quarter ended June 30, 2022.

  August 9, 2022

   · 

  7 min read
• Business

  Appia Bio Appoints Margo Roberts, Ph.D. to its Board of Directors and Names Jason Damiano, Ph.D. as Chief Scientific Officer

  Appia Bio, Inc. today announced the appointment of Margo Roberts, Ph.D. to its board of directors and Jason Damiano, Ph.D. as chief scientific officer (CSO).

  August 9, 2022

   · 

  4 min read
• Deals

  Emergent Acquires Evolutionary Biologics, Former L’Oréal President Jim Morrison to Become Full Time CEO of Emergent Effective August 15, 2022

  Emergent Health Corp. announces it has acquired Evolutionary Biologics, Inc.

  August 9, 2022

   · 

  5 min read
• Business

  PMV Pharmaceuticals Reports Second Quarter 2022 Financial Results and Corporate Highlights

  PMV Pharmaceuticals, Inc. (“PMV Pharma” Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today reported financial results for the second quarter ended June 30, 2022, and provided a corporate update.

  August 9, 2022

   · 

  8 min read
• Business

  Protara Therapeutics Announces Second Quarter 2022 Financial Results and Business Overview

  Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced financial results for the second quarter ended June 30, 2022 and provided a business update.

  August 9, 2022

   · 

  11 min read
• Business

  Black Diamond Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

  Black Diamond Therapeutics, Inc. today reported financial results for the second quarter ended June 30, 2022 and provided a corporate update.

  August 9, 2022

   · 

  8 min read